title: Urgent Chemotherapy for Life-Threatening Complications Related to Solid Neoplasms.
abstract: OBJECTIVE
  Solid neoplasms can be directly responsible for organ failures at the time of diagnosis or relapse. The management of such specific complications relies on urgent chemotherapy and eventual instrumental or surgical procedures, combined with advanced life support. We conducted a multicenter study to address the prognosis of this condition.
  
  
  METHODS
  A multicenter retrospective (2001-2015) chart review.
  
  
  METHODS
  Medical and respiratory ICUs.
  
  
  METHODS
  Adult patients who received urgent chemotherapy in the ICU for organ failure related to solid neoplasms were included. The modalities of chemotherapy, requirements of adjuvant instrumental or surgical procedures, and organ supports were collected. Endpoints were short- and long-term survival rates.
  
  
  METHODS
  None.
  
  
  RESULTS
  One hundred thirty-six patients were included. Lung cancer was the most common malignancy distributed into small cell lung cancer (n = 57) and non-small cell lung cancer (n = 33). The main reason for ICU admission was acute respiratory failure in 111 patients (81.6%), of whom 89 required invasive mechanical ventilation. Compression and tissue infiltration by tumor cells were the leading mechanisms resulting in organ involvement in 78 (57.4%) and 47 (34.6%) patients. The overall in-ICU, in-hospital, 6-month, and 1-year mortality rates were 37%, 58%, 74%, and 88%, respectively. Small cell lung cancer was identified as an independent predictor of hospital survival. However, this gain in survival was not sustained since the 1-year survival rates of small cell lung cancer, non-small cell lung cancer, and non-lung cancer patients all dropped below 20%.
  
  
  CONCLUSIONS
  Urgent chemotherapy along with aggressive management of organ failures in the ICU can be lifesaving in very selected cancer patients, most especially with small cell lung cancer, although the long-term survival is hardly sustainable.
authors.affiliation: 1Réanimation médicale, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris & Université Paris Descartes, Paris, France.2Pneumologie et Soins Intensifs Respiratoires, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.3Réanimation Médico-chirurgicale, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.4Réanimation médicale, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.5Pneumologie et réanimation respiratoire, Centre Hospitalier Universitaire d'Amiens, Amiens, France.6Réanimation médicale et Unité de Soins Continus, Hôpital Pitié Salpetrière, Assistance Publique-Hôpitaux de Paris, Paris, France.7Réanimation médicale, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Paris, France.8Médecine intensive et Réanimation, Groupe hospitalier Paris Saint-Joseph, Paris, France.9Réanimation médicale, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.10Réanimation Médico-Chirurgicale, Centre Hospitalier André Mignot, Versailles, France.11Réanimation médicale, Centre Hospitalier Universitaire d'Amiens, Amiens, France.12Réanimation Polyvalente, Hôpital Robert Ballanger, Aulnay-sous-Bois, France.13Réanimation Polyvalente, Hôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris, Clamart, France.14Réanimation Polyvalente et USC, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France.15Réanimation chirurgicale, Centre Hospitalier Universitaire d'Amiens, Amiens, France.16Réanimation chirurgicale, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
authors.forename: Yoann
authors.initials: Y
authors.lastname: Zerbib
authors.forename: Antoine
authors.initials: A
authors.lastname: Rabbat
authors.forename: Muriel
authors.initials: M
authors.lastname: Fartoukh
authors.forename: Naïke
authors.initials: N
authors.lastname: Bigé
authors.forename: Claire
authors.initials: C
authors.lastname: Andréjak
authors.forename: Julien
authors.initials: J
authors.lastname: Mayaux
authors.forename: Nicolas
authors.initials: N
authors.lastname: De Prost
authors.forename: Benoît
authors.initials: B
authors.lastname: Misset
authors.forename: Virginie
authors.initials: V
authors.lastname: Lemiale
authors.forename: Fabrice
authors.initials: F
authors.lastname: Bruneel
authors.forename: Julien
authors.initials: J
authors.lastname: Maizel
authors.forename: Sylvie
authors.initials: S
authors.lastname: Ricome
authors.forename: Frédéric
authors.initials: F
authors.lastname: Jacobs
authors.forename: Caroline
authors.initials: C
authors.lastname: Bornstain
authors.forename: Hervé
authors.initials: H
authors.lastname: Dupont
authors.forename: François
authors.initials: F
authors.lastname: Baudin
authors.forename: Elie
authors.initials: E
authors.lastname: Azoulay
authors.forename: Frédéric
authors.initials: F
authors.lastname: Pène
mesh_terms: D018806:APACHE; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015897:Comorbidity; D006801:Humans; D007362:Intensive Care Units; D008020:Life Support Care / Q000379:methods*; D008175:Lung Neoplasms / Q000628:therapy; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D063305:Organ Dysfunction Scores; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D000970:Antineoplastic Agents